Concepedia

R. V. Larocca

RV

Statistics

Publications

9

Citations

950

H-Index

9

Active since

1987

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Dana-Farber Cancer Institute

R. V. Larocca is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

Publications per year

1987–2014

9

Publications

9

Suramin: an anticancer drug with a unique mechanism of action.

C.A. Stein, R. V. Larocca, Rose V. Thomas et al. · Journal of Clinical Oncology · 1989 · 376 citations

, , +13

Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer.

Christopher D. Myers, Michael R. Cooper, C.A. Stein et al. · Journal of Clinical Oncology · 1992 · 237 citations

, , +12

Genetic Changes in Human Adrenocortical Carcinomas

Tomohiro Yano, M. Linehan, P. Angland et al. · JNCI Journal of the National Cancer Institute · 1989 · 129 citations

, , +15

A phase II trial of gefitinib monotherapy in patients with unresectable adrenocortical carcinoma (ACC)

Vivek Samnotra, Rena Vassilopoulou‐Sellin, Antonio Tito Fojo et al. · Journal of Clinical Oncology · 2007 · 52 citations

, , +9

Effects of Suramin on the Function and Structure of the Adrenal Cortex in the Cynomolgus Monkey

Penelope Feuillan, Mark Raffeld, C.A. Stein et al. · The Journal of Clinical Endocrinology & Metabolism · 1987 · 41 citations

, , +16

1–5 of 9